Catalyst Wire Dossier Catalyst Wire Dossier

Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccine

TARP peptide autologous dendritic cell vaccine · National Cancer Institute (NCI)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccine, covering 2022-09-15 to 2022-09-15. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 [Phase 2]

See pricing